Atle Fund Management AB
Filing Date
Global Rank
#4,596
/ 8,798
▼ 540
· as of Jun 2026
Top Industry
Biotechnology
38.0%
3Y Alpha vs SPY
-16.8%
Period ended 3 months ago
Filed Jul 24, 2026 · 3mo
20 quarters · since Dec 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
39 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
9.6%
−0.7 pts
Top 5
30.4%
−8.6 pts
Top 10
48.0%
−12.0 pts
HHI
375
Diversified−115
Portfolio Trend
20 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $371,706,262 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | +1,006,762 | 1,048,593 | $2,296,418 | |
| PYXS | Pyxis Oncology, Inc. | +769,423 | 966,459 | $2,909,041 | |
| TNGX | Tango Therapeutics, Inc. | +168,642 | 198,557 | $6,206,891 | |
| MRK | Merck & Co., Inc. | +155,504 | 189,357 | $24,332,374 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +154,052 | 248,848 | $8,433,458 | |
| CVS | CVS HEALTH Corp | +122,329 | 146,102 | $15,114,251 | |
| IONS | Ionis Pharmaceuticals Inc | +109,258 | 137,131 | $10,873,116 | |
| BSX | Boston Scientific Corp | +105,949 | 146,381 | $6,247,541 | |
| IDYA | IDEAYA Biosciences, Inc. | +63,345 | 94,478 | $3,521,195 | |
| IRTC | iRhythm Holdings, Inc. | +31,780 | 54,102 | $6,435,432 | |
| ABVX | Abivax S.A. | +26,580 | 58,170 | $7,751,734 | |
| BBIO | BridgeBio Pharma, Inc. | +13,344 | 124,707 | $9,288,177 | |
| COR | Cencora, Inc. | +7,656 | 31,126 | $8,808,035 | |
| INCY | Incyte Corp | +6,157 | 56,953 | $6,456,192 | |
| TMO | Thermo Fisher Scientific Inc. | +4,873 | 27,859 | $13,967,388 | |
| SYK | Stryker Corp | +3,448 | 30,283 | $9,534,299 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | −1,023,977 | 145,657 | $4,324,556 | |
| RVMD | Revolution Medicines, Inc. | −544,168 | 73,077 | $13,685,860 | |
| DXCM | Dexcom Inc | −512,486 | 71,846 | $4,838,828 | |
| CELC | Celcuity Inc. | −107,983 | 33,313 | $3,485,206 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −94,961 | 100,807 | $11,801,475 | |
| CAH | Cardinal Health Inc | −85,052 | 23,630 | $5,613,542 | |
| IRON | Disc Medicine, Inc. | −63,573 | 43,682 | $3,194,901 | |
| ISRG | Intuitive Surgical Inc | −46,195 | 24,656 | $9,805,198 | |
| ABBV | AbbVie Inc. | −43,856 | 64,325 | $16,186,743 | |
| INSM | INSMED Inc | −39,060 | 58,378 | $6,224,262 | |
| ALKS | Alkermes plc. | −29,144 | 213,329 | $11,178,439 | |
| NBIX | Neurocrine Biosciences Inc | −16,787 | 72,898 | $12,286,228 | |
| KRYS | Krystal Biotech, Inc. | −13,560 | 24,019 | $8,927,141 | |
| LLY | ELI LILLY & Co | −9,901 | 29,821 | $35,768,205 | |
| JNJ | Johnson & Johnson | −6,952 | 85,425 | $21,695,387 | |
| ONC | BeOne Medicines Ltd. | −6,537 | 35,180 | $10,025,244 | |
| SYRE | Spyre Therapeutics, Inc. | −5,705 | 57,030 | $5,063,123 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −3,853 | 19,131 | $9,502,941 | |
| EW | Edwards Lifesciences Corp | −3,288 | 103,230 | $9,338,185 | |
| GILD | Gilead Sciences, Inc. | −1,825 | 46,142 | $5,829,580 | |
| No positions match the current search. | |||||
39 tracked positions ·
$371,706,262 total
· filing declares
39 positions · $371,704,828
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 29,821 | $35,768,205 | 9.62% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 189,357 | $24,332,374 | 6.55% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 85,425 | $21,695,387 | 5.84% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 64,325 | $16,186,743 | 4.35% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 146,102 | $15,114,251 | 4.07% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 27,859 | $13,967,388 | 3.76% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 73,077 | $13,685,860 | 3.68% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 62,781 | $13,564,462 | 3.65% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 72,898 | $12,286,228 | 3.31% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 100,807 | $11,801,475 | 3.17% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 213,329 | $11,178,439 | 3.01% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 137,131 | $10,873,116 | 2.93% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Reduced | 35,180 | $10,025,244 | 2.70% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 24,656 | $9,805,198 | 2.64% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 30,283 | $9,534,299 | 2.57% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 19,131 | $9,502,941 | 2.56% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 103,230 | $9,338,185 | 2.51% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 124,707 | $9,288,177 | 2.50% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 24,019 | $8,927,141 | 2.40% | |
| COR |
Cencora, Inc.
Healthcare
|
Added | 31,126 | $8,808,035 | 2.37% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 248,848 | $8,433,458 | 2.27% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 58,170 | $7,751,734 | 2.09% | |
| INCY |
Incyte Corp
Healthcare
|
Added | 56,953 | $6,456,192 | 1.74% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 54,102 | $6,435,432 | 1.73% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 146,381 | $6,247,541 | 1.68% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 58,378 | $6,224,262 | 1.67% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 198,557 | $6,206,891 | 1.67% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 46,142 | $5,829,580 | 1.57% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Reduced | 23,630 | $5,613,542 | 1.51% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 54,886 | $5,223,500 | 1.41% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 57,030 | $5,063,123 | 1.36% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 71,846 | $4,838,828 | 1.30% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Reduced | 145,657 | $4,324,556 | 1.16% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 94,478 | $3,521,195 | 0.95% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 33,313 | $3,485,206 | 0.94% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 43,682 | $3,194,901 | 0.86% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Added | 966,459 | $2,909,041 | 0.78% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Added | 1,048,593 | $2,296,418 | 0.62% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
NEW | 88,556 | $1,967,714 | 0.53% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.